Pazufloxacin
It is a fused tricyclic quinolone derivative having potent broad specturm activity against gram-positive and gram-negative bacteria including variety of resistant strains and anaerobic bacteria.Respiratory Tract infections, urinary tract infections, abdominal infections, genital infection, secondary infections (after injuries, burns, and postoperative).
Recommended dose is 300 to 500mg twice a day administered as an I.V. infusion over 30-60 minutes. The total duration of therapy should not exceed 14 days. The maximum recomended dose in patient with moderate to severe renal failure should be 300 mg twice a day.
Hypersensitivity to any component of the formulation, pregnancy, infants and children.
Previous history of hypersensitivity for quinolone derivatives, severe renal damage, Convulsive disorders, Elderly.
Diarrhea, rashes, nausea and vomiting, Convulsions rarely.
Brand Name | Manufactured by |
---|---|
PAZACE | LUPIN LTD. |
PAZUBID | CADILA PHARMACEUTICALS LTD. |